Polymer Coated Curcumin Promises Effective Against Cancer

Nanocurcumin SolutionSolutions of curcumin (left) and nanocurcumin (right) in equal amounts. Credit: Johns Hopkins University.

Curcumin, an element found in the cooking spice turmeric has long been known to have positive effects against certain types of cancer. Effective treatments based on curcumin however have been limited due to its poor dissolving capabilities in water based substances, leading to low absorption rates when ingested. Researchers affiliated with the Institute for NanoBioTechnology at Johns Hopkins University report to have overcome this problem by encapsulating free curcumin with a polymeric nanoparticle, creating nanocurcumin.
[Read more...]

Winning Proposals in Therapeutics

Last December the Institute for NanoBioTechnology placed a call for proposals in the area of therapeutics. This was the third funding opportunity supported by INBT in one of it’s core research areas. Five winning proposals by Johns Hopkins faculty have been selected to receive $15,000 – $25,000 each.

[Read more...]

Johns Hopkins Nano-Bio Spring Symposium 2007

Spring SymposiumJHU NanoBio Spring Symposium, April 27, 2007

The first annual symposium for nanobiotechnology at Johns Hopkins Universtity will be held on Friday, April 27, 2007. The event takes place on JHU’s Homewood campus and will bring together faculty, students, industrial scientists and engineers, along with representatives from the federal government with an interest in the development and application of nanotechnology for biology and medicine.
[Read more...]

Nanomolecular Imaging at Johns Hopkins University

Cancer detection in intact animal. 23 g mouse, 300 mCi 18F-labeled PSMA, tumor on left side. Credit: SAIRP / JHU

Recent advances in materials science and in vivo molecular imaging have been the catalyst for an explosion in molecular imaging research. The use of nanodevices and nanoparticles has enabled the study of a wide variety of biological phenomena ranging from protein-protein interaction mapping to cancer detection in intact animals and man.

Key to those advances has been the emergence of functionalized nanoparticles which can be targeted specifically to molecules of biological importance such as receptors, enzymes and transporters, and have the ability to interact at the cellular level. Over the last five years there has also been a proliferation of high-resolution devices for in vivo imaging in animal models of human disease and high-throughput, such as microarray- and combinatorial-, techniques which are used to generate new targets and probes for diagnostics and therapeutics.

[Read more...]

Profile: Kate Stebe, Department of Chemical and Biomolecular Engineering

Stebe's research interests include the engineering of fluid interfaces, nanomaterials, and microfluidics.Stebe’s research interests include the engineering of fluid interfaces, nanomaterials, and microfluidics.

Kate Stebe is chair of the department of Chemical & Biomolecular Engineering at Johns Hopkins University and program director for one of INBT’s graduate degree programs. The following interview was previously published in Johns Hopkins Engineering, the magazine of the Johns Hopkins Whiting School of Engineering, winter 2007 (PDF).

Last July, professor Kate Stebe became chair of the Whiting School’s Department of Chemical and Biomolecular Engineering, a rapidly growing department with a faculty of 13. A member of the engineering school’s faculty since 1991, Stebe has served on the university’s Academic Council and was previously director of her department’s graduate program. Her research interests include the engineering of fluid interfaces, nanomaterials, and microfluidics. She holds a joint appointment with the Department of Biomedical Engineering and secondary appointments in Materials Science and Engineering and Mechanical Engineering. At the start of the fall semester, the magazine’s Abby Lattes sat down with Stebe, to talk about her vision for the future of Chemical and Biomolecular Engineering.

ChemBE is a fast-growing department. Can you discuss that growth and how you’re managing it?

This year alone we have 120 freshmen and have increased our graduate student yield by 100 percent— from 8 to 16 new graduate students. At the graduate level, we introduced a revised curriculum this past fall. We’ve returned to the fundamental courses in each discipline and amended them to include more timely examples. We’ve added required non-classical courses in topics such as interfaces and materials and others that emphasize opportunities and techniques in biomolecular engineering. At the undergraduate level, we’ve also seen explosive growth. This growth is due in part to students’ understanding of the scope of the problems we attack and their relevance to bio-related industries, such as protein-based pharmaceuticals and lab-on-a-chip devices. Meeting the challenges this growth presents while honoring our commitment to quality education will require care, focus, creativity, and plain old hard work.

In 2002 the department changed its name from Chemical Engineering to Chemical and Biomolecular Engineering. What prompted that change?

This department is built on a clear understanding of our strengths. We were a chemical engineering department with half of our faculty working as applied scientists on biological themes. Our redefinition was a recognition of this strength and where we knew we could make the greatest impact. We have two centers of excellence in the
Department — biomolecular engineering and our deep expertise in interfaces. We’re configured very tightly around these areas and poised to do fundamental work at their intersection.

How do you view advances in the field and your role as department chair?

Chemical engineering expertise in interfaces, made possible through our ability to control surfaces at the molecular level, now has important applications in micro- or nano-fluidics devices, micro mechanical electrical systems, and controlling the interactions of nanomaterials. Since the early 1990s, there’s been a lot of elegant work done by chemical engineers in bio-related problems—where complex ideas about chemical systems far from equilibrium are applied to our understanding of synthesis in cells and cell-cell interactions, for example. There are important applications to this work that range from using cells to produce chemical products to understanding plaque formation in heart disease or metastatic events in cancer. As a department, we all took part in the process of redefining who we are and have a highly unified vision about the direction in which we’re going. Now I’m in the driver’s seat to implement the vision.

What is the most fundamental element to the program’s success?

Our faculty. They are individual experts in their fields and highly integrated throughout the department and across other departments, divisions, and research centers and institutes. They’re young and ready to move in a common direction to pull us forward. This balance of individual expertise and shared vision makes the department a special place.

What message do you give to female students looking at careers in academia?

The life balance issues will always be there for women and I talk about this with my students. For example, when I go home, I’m “Mom,“ and turn my attention to my 5-year-old daughter. A tremendous advantage to working in academia is that we’re measured according to whether or not we’re productive and creative, not the hours we’ve logged. It’s an incredibly demanding profession, but it is also flexible. I don’t know if the opportunities created by that flexibility are always made clear to young people of either gender considering academic careers. It is possible to make it all work and it can be very rewarding.

What’s on the horizon?

We’re defining what the field should be. We’re attacking problems on the molecular and nano scale. We are poised to make a strong contribution to the fundamental issues in our field. It’s an exciting time in our department.

More info:

Nanomedicine Research Day at the University of Maryland

The Center for Nanomedicine and Cellular Delivery at the University of Maryland School of Pharmacy will organize their first Nanomedicine Research Day on March 23, 2007. The purpose of this symposium is to provide an overview of the research activities of the center and the local/regional nanomedicine community in an attempt to foster interactions in this new area of research.

Download the complete program (PDF format).

Visit the website of the Center for Nanomedicine at UMD.

Cellular and Molecular Dynamics – Winning Proposals Announced

After soliciting and reviewing proposals in one of INBT’s core research areas, Cellular & Molecular Dynamics, INBT recently awarded a total of $75,000 in seed funding, or $25,000 for each project, to three multi-disciplinary research teams at Johns Hopkins. The awards will jumpstart new investigations into nanobiotechnology.

Winning Proposals:

1) Andre Levchenko (Biomedical Eng) and Jin Zhang (Pharmacology and Neuroscience) “Nano- and micro-scale analysis of PKA regulation of cell locomotion”

2) Y. C. Lee (Biology), Hai-Quan Mao (Materials Science & Eng) and Shau-Ku Huang (Medicine) “Glyco-nanoparticles targeting dendritic cells for enhanced immune tolerance”

3) Chien-Fu Hung (Pathology) and Justin Hanes (Chemical Eng) “Polymeric nanoparticle drug delivery systems for the development of an immunogenic ovarian tumor cell-based vaccine”

Nanobiotechnologist – An interview with Peter Searson

In a recent interview conducted by Cogito, Peter Searson, JHU professor of Materials Science & Engineering and Director of the Institute for NanoBioTechnology, gives insightful answers to questions about his work, INBT, and nanobiotechnology in general.

What’s the coolest thing that’s happened at the Institute so far this year?

“…One of the most exciting things for me is that we have established many new collaborations between researchers in engineering/physical sciences and life sciences / medicine. I am convinced that we will start to see some incredible new technologies as a result of these collaborations in the future…” says Searson.

Read the full interview here;

Interview with Peter Searson on Cogito.org.

Coated Nanoparticles Slip Through Mucus

Researchers at Johns Hopkins University have discovered a way to make larger nanoparticles slip through mucus. The secret is to coat them with the molecule polyethylene glycol (PEG), says Justin Hanes, Associate Professor of Chemical and Biomolecular Engineering and member of the Institute for NanoBiotechnology at Johns Hopkins. “This method of drug delivery could be used for literally most pharmaceuticals that are swallowed”, according to Hanes… >> read more on Headlines at Hopkins

also covered on:


Genetic Insights into Parkinsons Disease

diagram demonstrates how the LRRK2 gene is related to kinase activity and neural cell toxicity.
The diagram demonstrates how the LRRK2 gene is related to kinase activity and neural cell toxicity. Credit: Ted M. Dawson/Johns Hopkins

A chronic disorder of the central nervous system, Parkinson’s Disease (PD) is currently treated with drugs that may slow progression of its physical symptoms – including tremors, impaired balance, and rigidity – but lack significant effect on the progression of the disease itself. Ted Dawson and members of his research team at Johns Hopkins have been at the forefront of research identifying the role and function of genes in the pathogenesis of PD for years. [Read more...]